Propylene Oxide → cis-3-(1H-tetrazol-1-ylacetamido)-2-oxoazetidine-4-carboxylic acid methyl ester

HRID 621045Notes

Reaction equation

HRID 621045 reaction equation
[CH3:1][O:2][C:3]([C@H:5]1[NH:8][C:7](=[O:9])[C@H:6]1[NH2:10])=[O:4].C1OC1C.CN(C)C(=O)C.[N:21]1([CH2:26][C:27](Cl)=[O:28])[CH:25]=[N:24][N:23]=[N:22]1>C(OCC)C>[CH3:1][O:2][C:3]([C@H:5]1[NH:8][C:7](=[O:9])[C@H:6]1[NH:10][C:27](=[O:28])[CH2:26][N:21]1[CH:25]=[N:24][N:23]=[N:22]1)=[O:4]

Participants

6

Conditions

Temperature
-30 °C

Procedure

To a mixture of 288 mg of cis-3-amino-2-oxoazetidine-4-carboxylic acid methyl ester, 4 ml of propylene oxide and 3 ml of N,N-dimethylacetamide, which is stirred previously under ice-cooling, is added dropwise 400 mg of 1H-tetrazol-1-yl acetyl chloride, followed by stirring for 30 minutes. To the mixture is added 50 ml of ethyl ether, followed by stirring under cooling at -30° C., and then the upper layer is removed by decantation. The lower layer is subjected to the same procedure as above twice, followed by addition of 10 ml of acetone. The resultant solution is developed and purified by column-chromatography on silica-gel (40 g, 3×10 cm) using a mixture of acetone:methylene chloride (1:1) as eluent, followed by drying to give 403 mg (84%) of cis-3-(1H-tetrazol-1-ylacetamido)-2-oxoazetidine-4-carboxylic acid methyl ester.

Workup

  1. temperaturecooling
  2. stirringby stirring for 30 minutes
  3. stirringby stirring
  4. customthe upper layer is removed by decantation
  5. additionfollowed by addition of 10 ml of acetone
  6. custompurified by column-chromatography on silica-gel (40 g, 3×10 cm)
  7. additiona mixture of acetone:methylene chloride (1:1) as eluent
  8. customby drying

Sources & evidence

ORD record
ord-bff7cb52d36043f0b379126330637ef6
Source dataset
uspto-grants-1989_04
Patent number
US04822790

Reaction notes

Loading…